185 related articles for article (PubMed ID: 28006907)
1. Differences in Metabolism of Ellagitannins by Human Gut Microbiota ex Vivo Cultures.
Piwowarski JP; Granica S; Stefańska J; Kiss AK
J Nat Prod; 2016 Dec; 79(12):3022-3030. PubMed ID: 28006907
[TBL] [Abstract][Full Text] [Related]
2. Role of human gut microbiota metabolism in the anti-inflammatory effect of traditionally used ellagitannin-rich plant materials.
Piwowarski JP; Granica S; Zwierzyńska M; Stefańska J; Schopohl P; Melzig MF; Kiss AK
J Ethnopharmacol; 2014 Aug; 155(1):801-9. PubMed ID: 24969824
[TBL] [Abstract][Full Text] [Related]
3. Urolithins, gut microbiota-derived metabolites of ellagitannins, inhibit LPS-induced inflammation in RAW 264.7 murine macrophages.
Piwowarski JP; Kiss AK; Granica S; Moeslinger T
Mol Nutr Food Res; 2015 Nov; 59(11):2168-77. PubMed ID: 26202092
[TBL] [Abstract][Full Text] [Related]
4. UV and MS identification of Urolithins and Nasutins, the bioavailable metabolites of ellagitannins and ellagic acid in different mammals.
González-Barrio R; Truchado P; Ito H; Espín JC; Tomás-Barberán FA
J Agric Food Chem; 2011 Feb; 59(4):1152-62. PubMed ID: 21265540
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of oak leaf ellagitannins and urolithin production in beef cattle.
González-Barrio R; Truchado P; García-Villalba R; Hervás G; Frutos P; Espín JC; Tomás-Barberán FA
J Agric Food Chem; 2012 Mar; 60(12):3068-77. PubMed ID: 22375726
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stability of urolithins: an in vitro approach.
Mena P; Dall'Asta M; Calani L; Brighenti F; Del Rio D
Eur J Nutr; 2017 Feb; 56(1):99-106. PubMed ID: 26439723
[TBL] [Abstract][Full Text] [Related]
7. Influence of gut microbiota-derived ellagitannins' metabolites urolithins on pro-inflammatory activities of human neutrophils.
Piwowarski JP; Granica S; Kiss AK
Planta Med; 2014 Jul; 80(11):887-95. PubMed ID: 24995502
[TBL] [Abstract][Full Text] [Related]
8. Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species.
Selma MV; Beltrán D; García-Villalba R; Espín JC; Tomás-Barberán FA
Food Funct; 2014 Aug; 5(8):1779-84. PubMed ID: 24909569
[TBL] [Abstract][Full Text] [Related]
9. Pomegranate's Neuroprotective Effects against Alzheimer's Disease Are Mediated by Urolithins, Its Ellagitannin-Gut Microbial Derived Metabolites.
Yuan T; Ma H; Liu W; Niesen DB; Shah N; Crews R; Rose KN; Vattem DA; Seeram NP
ACS Chem Neurosci; 2016 Jan; 7(1):26-33. PubMed ID: 26559394
[TBL] [Abstract][Full Text] [Related]
10. Strawberry processing does not affect the production and urinary excretion of urolithins, ellagic acid metabolites, in humans.
Truchado P; Larrosa M; García-Conesa MT; Cerdá B; Vidal-Guevara ML; Tomás-Barberán FA; Espín JC
J Agric Food Chem; 2012 Jun; 60(23):5749-54. PubMed ID: 22126674
[TBL] [Abstract][Full Text] [Related]
11. C-glucosidic ellagitannins from Lythri herba (European Pharmacopoeia): chromatographic profile and structure determination.
Piwowarski JP; Kiss AK
Phytochem Anal; 2013; 24(4):336-48. PubMed ID: 23280650
[TBL] [Abstract][Full Text] [Related]
12. Colonic catabolism of ellagitannins, ellagic acid, and raspberry anthocyanins: in vivo and in vitro studies.
González-Barrio R; Edwards CA; Crozier A
Drug Metab Dispos; 2011 Sep; 39(9):1680-8. PubMed ID: 21622625
[TBL] [Abstract][Full Text] [Related]
13. Identification of urolithin a as a metabolite produced by human colon microflora from ellagic acid and related compounds.
Cerdá B; Periago P; Espín JC; Tomás-Barberán FA
J Agric Food Chem; 2005 Jul; 53(14):5571-6. PubMed ID: 15998116
[TBL] [Abstract][Full Text] [Related]
14. Chromatographic and spectroscopic characterization of urolithins for their determination in biological samples after the intake of foods containing ellagitannins and ellagic acid.
García-Villalba R; Espín JC; Tomás-Barberán FA
J Chromatogr A; 2016 Jan; 1428():162-75. PubMed ID: 26341594
[TBL] [Abstract][Full Text] [Related]
15. Effects of ellagitannin-rich berries on blood lipids, gut microbiota, and urolithin production in human subjects with symptoms of metabolic syndrome.
Puupponen-Pimiä R; Seppänen-Laakso T; Kankainen M; Maukonen J; Törrönen R; Kolehmainen M; Leppänen T; Moilanen E; Nohynek L; Aura AM; Poutanen K; Tómas-Barberán FA; Espín JC; Oksman-Caldentey KM
Mol Nutr Food Res; 2013 Dec; 57(12):2258-63. PubMed ID: 23934737
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice.
González-Sarrías A; Giménez-Bastida JA; García-Conesa MT; Gómez-Sánchez MB; García-Talavera NV; Gil-Izquierdo A; Sánchez-Alvarez C; Fontana-Compiano LO; Morga-Egea JP; Pastor-Quirante FA; Martínez-Díaz F; Tomás-Barberán FA; Espín JC
Mol Nutr Food Res; 2010 Mar; 54(3):311-22. PubMed ID: 19885850
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Bioaccessibility, Human Gut Microbiota Metabolites and Hepatoprotective Potential of Chebulic Ellagitannins: A Case of Padma Hepaten® Formulation.
Olennikov DN; Kashchenko NI; Chirikova NK
Nutrients; 2015 Oct; 7(10):8456-77. PubMed ID: 26473917
[TBL] [Abstract][Full Text] [Related]
18. Reinvestigation of the stereochemistry of the C-glycosidic ellagitannins, vescalagin and castalagin.
Matsuo Y; Wakamatsu H; Omar M; Tanaka T
Org Lett; 2015 Jan; 17(1):46-9. PubMed ID: 25496565
[TBL] [Abstract][Full Text] [Related]
19. Antiatherogenic effects of ellagic acid and urolithins in vitro.
Mele L; Mena P; Piemontese A; Marino V; López-Gutiérrez N; Bernini F; Brighenti F; Zanotti I; Del Rio D
Arch Biochem Biophys; 2016 Jun; 599():42-50. PubMed ID: 26891591
[TBL] [Abstract][Full Text] [Related]
20. Urolithins are the main urinary microbial-derived phenolic metabolites discriminating a moderate consumption of nuts in free-living subjects with diagnosed metabolic syndrome.
Tulipani S; Urpi-Sarda M; García-Villalba R; Rabassa M; López-Uriarte P; Bulló M; Jáuregui O; Tomás-Barberán F; Salas-Salvadó J; Espín JC; Andrés-Lacueva C
J Agric Food Chem; 2012 Sep; 60(36):8930-40. PubMed ID: 22631214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
